-
N3-kethoxal for Guanine Accessibility Mapping
2026-09-15
N3-kethoxal converts exposed guanines into clickable structural records, helping researchers connect nucleic acid conformation with protein binding and cellular accessibility. This guide translates that chemistry into practical workflows, including a careful strategy for studying NET-associated ssDNA and thrombin interactions.
-
Bardoxolone Methyl: Redox Workflow Guide
2026-09-15
Build practical redox assays around Bardoxolone methyl, from Nrf2 and NF-kB pathway readouts to thioredoxin-linked cancer experiments. This guide emphasizes solvent handling, time-resolved controls, combination hypotheses, and troubleshooting across kidney, leukemia, and lung models.
-
Nocodazole Workflows for Microtubule Research
2026-09-14
Nocodazole offers reversible control of β-tubulin assembly for live-cell imaging, mitotic enrichment, trafficking studies, and anticancer drug evaluation. This practical guide connects dose design and washout experiments with a cautious framework for interpreting chromatin and DNA damage phenotypes.
-
Nifedipine Workflows for Calcium and Liver Studies
2026-09-14
Nifedipine (BAY-a-1040) offers a practical L-type calcium channel perturbation for linking calcium influx inhibition with cell viability, transport, contraction, and pathogen biology. This workflow also shows how to add a calcium-focused arm to PXR, CYP, and liver-regeneration studies without confusing channel blockade with direct PXR activation.
-
Indole-3-Pyruvic Acid: Mechanism to Assay Design
2026-09-13
Indole-3-pyruvic acid is more than an auxin precursor: it is a context-dependent metabolic signal linking pathway control, fungal validation, and immune biology. This guide explains how to interpret IPA experiments, select meaningful controls, and distinguish established mechanisms from preclinical hypotheses.
-
Amyloid Beta-peptide (25-35) Neurotoxicity Model
2026-09-12
Amyloid Beta-peptide (25-35), also called Aβ25-35, is a synthetic human amyloid beta fragment used as a compact Alzheimer's disease neurotoxicity model. It supports controlled studies of neuronal injury, oxidative stress, amyloid aggregation, and microglial inflammatory signaling.
-
Butylated Hydroxyanisole (BHA) Assay Workflows
2026-09-11
Build more interpretable oxidative stress experiments with Butylated hydroxyanisole (BHA), using controlled solvent, timing, and orthogonal readouts. This workflow treats BHA as a redox perturbation tool rather than a universal rescue reagent, helping distinguish ROS changes from downstream effects on viability, apoptosis, or inflammation.
-
CHI3L1-IN-5 Workflow for Neuroinflammation
2026-09-11
CHI3L1-IN-5, also called Compound Z17, combines CNS-relevant exposure characteristics with a focused strategy for probing CHI3L1-driven inflammation. This workflow connects NF-κB signaling, astrocyte Aβ uptake, and lysosomal endpoints while separating product-backed findings from practical assay starting conditions.
-
GSK621: AMPK Agonist at the AML Frontier
2026-09-10
GSK621 offers translational researchers a potent AMPK agonist for connecting energy sensing with AML biology, apoptosis, autophagy, and immunometabolic questions. This article integrates AML evidence with the 25-hydroxycholesterol–AMPK macrophage axis while distinguishing established findings from testable hypotheses.
-
TerminaTOR Maps Nuclear mTORC1 Transcriptional Control
2026-09-10
The reference study introduces TerminaTOR, a genetically encodable inhibitor that can selectively perturb mTORC1 at defined subcellular locations. By contrasting lysosomal and nuclear inhibition, the work shows that nuclear mTORC1 regulates transcription of CCAAT motif-containing genes, revealing functional spatial compartmentalization beyond canonical nutrient signaling.
-
Heterologous Regulators Improve Teicoplanin and A40926
2026-09-09
Zhukrovska and colleagues show that StrR-like regulatory proteins can act across phylogenetically distant antibiotic biosynthetic pathways. Heterologous expression of chers28 improved teicoplanin and A40926 production, whereas ramo5 did not, highlighting regulatory cross-talk as a selective strategy for activating or optimizing biosynthetic gene clusters.
-
Baicalin Methyl Ester for Intestinal Barrier Studies
2026-09-09
Baicalin methyl ester is an esterified derivative of baicalin suited to mechanistic studies of LPS-induced intestinal barrier damage. Its value lies in pairing cytokine suppression with tight-junction restoration across MODE-K cell and mouse workflows.
-
Viperin Targets Coronavirus nsp8 to Block Replication
2026-09-08
The reference study identifies a previously unrecognized anti-coronavirus mechanism in which viperin binds nsp8, disrupts replication-transcription complex assembly, and reduces viral RNA polymerase activity. Using porcine deltacoronavirus as a model, the work separates this protein-interaction mechanism from ddhCTP-mediated chain termination and suggests a possible basis for broader antiviral drug development.
-
Bortezomib (PS-341) and the PDAR Apoptosis Axis
2026-09-08
Bortezomib (PS-341) is a reversible 20S proteasome inhibitor that provides a powerful entry point for dissecting proteostasis-driven cell death. This article connects proteasome perturbation with the 2025 discovery of Pol II degradation-dependent apoptosis while defining practical assays that distinguish target engagement from downstream mitochondrial signaling.
-
ML216: BLM Helicase Inhibitor Research Workflow
2026-09-07
ML216 enables controlled interrogation of BLM-dependent DNA repair, homologous recombination, sister chromatid exchange, and chemotherapy response. This practical guide connects biochemical testing with paired cellular models while clearly distinguishing BLM-focused experiments from WRN–MSI findings in colorectal cancer.